Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P06889 (
Mol
)
630,302
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
(1) Antioxidants are involved in body protection mechanisms against reactive oxygen species. Amino acids such as glutathione (GSH) and
N
-acetylcysteine (NAC) are known to be involved in providing protection against oxidative lethality. A quick and simple method for the determination of NAC and GSH in various biological matrices such as urine, plasma, and homogenates of brain tissues has been developed and described in this work. (2) The assay is based on reversed phase high performance liquid chromatography with spectrofluorimetric detection and on-column derivatization.
Butylamine
and
o
-phthaldialdehyde have been used as derivatization reagents. Since
o
-phthaldialdehyde constitutes a part of the mobile phase, the derivatization reaction and chromatographic separation occur simultaneously. (3) Linearity in the detector response for NAC in human urine was observed in the range of 5-200 nmol mL
-1
, and NAC and GSH in the brain tissue homogenates were observed in the range of 0.5-5 nmol mL
-1
and 0.5-15 nmol mL
-1
, respectively. Human plasma linearity ranges covered 0.25-5.00 nmol mL
-1
and 0.5-15 nmol mL
-1
for NAC and GSH, respectively. The LODs for NAC and GSH were 0.01 and 0.02 nmol mL
-1
while the LOQs were 0.02 and 0.05 nmol mL
-1
, respectively. The usefulness of the proposed method was proven through its application to real samples.
Int J
Mol
Sci 2019 Jul 07
PMID:Application of Butylamine as a Conjugative Reagent to On-Column Derivatization for the Determination of Antioxidant Amino Acids in Brain Tissue, Plasma, and Urine Samples. 3128 71